Higher scores in the Clinical Frailty Scale are associated with covert and overt hepatic encephalopathy in patients with cirrhosis.

[1]  K. Reddy,et al.  Role Of Oral Health, Frailty and Minimal Hepatic Encephalopathy In The Risk Of Hospitalization: A Prospective Multi-Center Cohort Of Outpatients with Cirrhosis. , 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  C. Labenz,et al.  Ammonia - an old friend with a new area of application. , 2022, Journal of hepatology.

[3]  J. Bajaj,et al.  Specific Challenges in Geriatric Cirrhosis and Hepatic Encephalopathy. , 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  R. Jalan,et al.  Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis. , 2022, Journal of hepatology.

[5]  J. Schattenberg,et al.  Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver Cirrhosis , 2022, Clinical and translational gastroenterology.

[6]  J. Schattenberg,et al.  Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis , 2022, Diagnostics.

[7]  P. Galle,et al.  Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis , 2022, Hepatology communications.

[8]  D. Ganger,et al.  Cognitive Impairment and Physical Frailty in Patients With Cirrhosis , 2021, Hepatology communications.

[9]  R. Vilaichone,et al.  Frailty as tested by the Liver Frailty Index is associated with decompensation and unplanned hospitalization in patients with compensated cirrhosis , 2021, Scandinavian journal of gastroenterology.

[10]  A. Duseja,et al.  A Comparison of Different Frailty Scores and Impact of Frailty on Outcome in Patients With Cirrhosis. , 2021, Journal of clinical and experimental hepatology.

[11]  A. Montano‐Loza,et al.  Sarcopenia and frailty in decompensated cirrhosis. , 2021, Journal of hepatology.

[12]  E. Tapper,et al.  Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis. , 2020, The American journal of gastroenterology.

[13]  P. Galle,et al.  Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosis , 2020, Alimentary pharmacology & therapeutics.

[14]  S. Pungpapong,et al.  Association between sarcopenia and hepatic encephalopathy: A systematic review and meta-analysis. , 2020, Annals of hepatology.

[15]  T. H. Nguyen,et al.  The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The lancet. Gastroenterology & hepatology.

[16]  C. Strassburg,et al.  Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis. , 2020, Journal of hepatology.

[17]  J. Schattenberg,et al.  Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies , 2020, Zeitschrift für Gastroenterologie.

[18]  G. Su,et al.  Bedside Measures of Frailty and Cognitive Function Correlate with Sarcopenia in Patients with Cirrhosis , 2019, Digestive Diseases and Sciences.

[19]  D. Ganger,et al.  Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. , 2019, Gastroenterology.

[20]  A. Jindal,et al.  Sarcopenia: Ammonia metabolism and hepatic encephalopathy , 2019, Clinical and molecular hepatology.

[21]  P. Galle,et al.  Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy. , 2019, European journal of internal medicine.

[22]  Runping Liu,et al.  Effect of Increasing Age on Brain Dysfunction in Cirrhosis , 2018, Hepatology communications.

[23]  N. Tangri,et al.  Predicting Hepatic Encephalopathy‐Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients With Cirrhosis , 2018, The American Journal of Gastroenterology.

[24]  P. Galle,et al.  Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients , 2018, Alimentary pharmacology & therapeutics.

[25]  P. Angeli,et al.  The animal naming test: An easy tool for the assessment of hepatic encephalopathy , 2017, Hepatology.

[26]  N. Tangri,et al.  A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty Scale , 2016, The American Journal of Gastroenterology.

[27]  Roger Williams,et al.  Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. , 2004, Journal of hepatology.

[28]  K Weissenborn,et al.  Neuropsychological characterization of hepatic encephalopathy. , 2001, Journal of hepatology.

[29]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.